Treatment of nearly 2000 cases of cancer patients in 4 years! Shanghai Proton Heavy Ion Hospital Shines "Report Card"

(Health Times Network End Department reporter Wei Wei in Shanghai Proton Heavy Ion Hospital Fu Qing) "As of May 2019, the hospital has admitted a total of 1945 patients in the four years since its establishment, covering more than 40 kinds of cancer diseases, of which 1871 patients have completed treatment and discharge." Professor Guo Xiaomao, director of The Shanghai Proton Heavy Ion Hospital (The Proton Heavy Ion Center of Fudan University's Affiliated Oncology Hospital), said.On the 4th anniversary of the , patients participated in the
this four-year-old clinical and scientific research "report card" shows that Shanghai Proton Heavy Ion Hospital relies on the advantages of heavy ion technology, around nasopharyngeal cancer, intracranial tumor, early lung cancer, liver cancer, prostate cancer and other five key diseases to carry out clinical treatment, and pancreatic cancer to carry out key clinical research ("5-1" key diseases), the current number of key treatment cases accounted for 63%.Professor Guo Xiaomao,
, since June 2014 to participate in clinical trials 35 patients in the past 5 years follow-up results showed that excluding non-tumor causes, clinical trial patients in the last 5 years of the overall follow-up survival rate of 97.1%, nearly 5 years local tumor control rate of 81.8%.
" proton heavy ion therapy is particularly well suited to preserve patient life function and ensure future quality of life while rooting out early tumors due to its non-invasive, low side effects and precision strikes. According to Professor Guo Xiaomao, there were 1818 patients, or 93.5%, who treated all patients with heavy ions or heavy ion combined proton therapy, and 127 patients who were treated with protonthes alone (mainly in the initial treatment), accounting for 6.5%.
and for the treatment of refractive tumors, especially head and neck tumors, proton heavy ions also have great therapeutic advantages, breaking through some of the "bottlenecks" in past treatment sourcing. Of the 390 patients treated in the hospital, the number of patients with recurrent nasopharyngeal cancer accounted for 58%, and after heavy ion treatment, good results were achieved.
in the particle system equipment information system update research and development, the hospital independently developed the first set of more suitable for proton heavy ion "Chinese version" treatment process management information system, and has been formally put into clinical use. This system replaces the foreign version originally used by the hospital and greatly improves the matching degree with the hospital particle system equipment.
in this originally only foreign advanced developed countries have the right to speak in the field, Shanghai Proton Heavy Ion Hospital in practice has also formed a suitable for the characteristics of the Chinese people "China program", and gradually explore the basis of ensuring the efficacy, reduce the number of proton heavy ion treatment, improve the proportion of heavy ion treatment of China's "localization" diagnosis and treatment program.
.